Emergent BioSolutions to Present at 31st Annual J.P. Morgan Healthcare Conference Business Wire ROCKVILLE, Md. -- December 03, 2012 Emergent BioSolutions Inc. (NYSE: EBS) announced today that a member of the company’s senior management team will provide a corporate overview presentation at the 31^st Annual J.P. Morgan Healthcare Conference in San Francisco on Tuesday, January 8, 2013 at 10:00AM Pacific. The presentation may include a discussion of recent business developments, preliminary 2012 financial results and financial guidance for full year 2013. A webcast of this presentation will be available both live and by replay, accessible from the Emergent website www.emergentbiosolutions.com under “Investors”. About Emergent BioSolutions Inc. Emergent BioSolutions is a specialty pharmaceutical company seeking to protect and enhance life by offering specialized products to healthcare providers and governments to address medical needs and emerging health threats. Additional information about us may be found at www.emergentbiosolutions.com. Follow us on twitter: @emergentbiosolu. Contact: Emergent BioSolutions Inc. Investors Contact: Robert G. Burrows Vice President, Investor Relations 301-795-1877 BurrowsR@ebsi.com or Media Contact: Tracey Schmitt Vice President, Corporate Communications 301-795-1800 SchmittT@ebsi.com
Emergent BioSolutions to Present at 31st Annual J.P. Morgan Healthcare Conference
Press spacebar to pause and continue. Press esc to stop.